FIELD: pharmaceutical industry.
SUBSTANCE: chewing gum for reducing cravings for smoking, comprising: a gum core containing nicotine polacrilex, an outer coating covering the gum core containing at least one sugar alcohol or mixtures of sugar alcohols, a fraction fused onto the outer coating, the fraction containing nicotine bitartrate or dihydrate nicotine ditartrate and at least one sugar alcohol or a mixture of sugar alcohols, and the buffer is present in the coating and/or in the fraction deposited on the outer coating, wherein the sugar alcohol is selected from the group consisting of erythritol, xylitol, lactitol, mannitol, maltitol, isomalt, arabitol and sorbitol or mixtures thereof; the gum core contains 1 to 6 mg of nicotine; one fraction welded onto the outer coating contains from 0.25 to 2 mg of nicotine; one fraction deposited on the outer coating contains from 73 to 93% of sugar alcohol, expressed as % of the total mass of the fraction; the buffer is selected from sodium carbonate, sodium bicarbonate, potassium bicarbonate, trometamol or mixtures thereof and is present in the coating and/or in the fraction deposited on the outer coating in an amount of from 1 to 2.5 mg. Chewing gum is used to treat a person suffering from tobacco addiction.
EFFECT: chewing gum described above provides a sustained and immediate release of nicotine.
17 cl, 9 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
TABLETTED CHEWING GUMS | 2009 |
|
RU2501551C2 |
PRESSED NICOTINE LOZENGE | 2020 |
|
RU2825844C1 |
SOLID ORAL NICOTINE COMPOSITION | 2018 |
|
RU2786451C2 |
NICOTINE COMPOSITION FOR PERORAL APPLICATION, WHICH CONTAINS AMINO-ACID BUFFER | 2008 |
|
RU2465904C2 |
PHARMACEUTICAL PRODUCT FOR INTRAORAL NICOTINE ADMINISTRATION CONTAINING TROMETAMOL AS BUFFER AGENT | 2007 |
|
RU2436566C2 |
NICOTINE-CONTAINING CHEW WITH COVER, METHOD FOR ITS PREPARING AND USING | 2002 |
|
RU2291688C2 |
ION EXCHANGE COMPOSITION WITH WATER-SOLUBLE MUCOADHESIVE POLYMERS | 2020 |
|
RU2812603C1 |
SOLID NICOTINE-CONTAINING DOSAGE FORM WITH REDUCED UNPLEASANT ORGANOLEPTIC IMPACT | 2013 |
|
RU2623018C2 |
COATED PHARMACEUTICAL PRODUCT FOR ORAL NICOTINE DELIVERY CONTAINING TROMETAMOL AS BUFFERING AGENT | 2007 |
|
RU2448707C2 |
SACHET CONTAINING NICOTINE IN FORM OF FREE SALT | 2012 |
|
RU2608902C2 |
Authors
Dates
2023-04-04—Published
2019-07-12—Filed